Publication

Pembrolizumab plus chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study

Chung, HC
; 
Bang, YJ
; 
Tabernero, J
; 
Van Cutsem, E
; 
Fuchs, CS
; 
Wyrwicz, L
; 
Lee, KW
; 
Kudaba, I
; 
Garrido, M
; 
Castro, H
... show 8 more
Citations
Altmetric:
Abstract
Authors
Chung, HC
Bang, YJ
Tabernero, J
Van Cutsem, E
Fuchs, CS
Wyrwicz, L
Lee, KW
Kudaba, I
Garrido, M
Castro, H
Mansoor, Was
Braghiroli, MI
Goekkurt, E
Chao, J
Wainberg, ZA
Kher, U
Shah, S
Shitara, K
Affiliation
Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
Description
Date
2019
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Chung HC, Bang YJ, Tabernero J, Van Cutsem E, Fuchs CS, Wyrwicz L, et al. Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study. Annals of Oncology. 2019;30:ix43-ix4.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622695
Embedded videos